-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Kl43NPTaBBHt6BD3HHalpwGB+kiFB9mAySv8RolSh0BeEYvSYHtUdaGbEu7SAfV7 mjwjff8ZTL/0bynKjpGmAQ== 0001127602-10-006259.txt : 20100225 0001127602-10-006259.hdr.sgml : 20100225 20100225133710 ACCESSION NUMBER: 0001127602-10-006259 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100224 FILED AS OF DATE: 20100225 DATE AS OF CHANGE: 20100225 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KRAEUTLER JOHN A CENTRAL INDEX KEY: 0001224662 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14902 FILM NUMBER: 10632761 MAIL ADDRESS: STREET 1: 3471 RIVER HILLS DRIVE CITY: CINCINNATI STATE: OH ZIP: 45244 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERIDIAN BIOSCIENCE INC CENTRAL INDEX KEY: 0000794172 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 310888197 STATE OF INCORPORATION: OH FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 3471 RIVER HILLS DR CITY: CINCINNATI STATE: OH ZIP: 45244 BUSINESS PHONE: 5132713700 MAIL ADDRESS: STREET 1: 3471 RIVER HILLS DRIVE CITY: CINCINNATI STATE: OH ZIP: 45244 FORMER COMPANY: FORMER CONFORMED NAME: MERIDIAN DIAGNOSTICS INC DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2010-02-24 0000794172 MERIDIAN BIOSCIENCE INC VIVO 0001224662 KRAEUTLER JOHN A 3471 RIVER HILLS DRIVE CINCINNATI OH 45244 1 1 Chief Executive Officer Common Stock 2010-02-24 4 S 0 25600 22.00 D 225260 D As a result of technological limitations of the EDGAR system, this Form 4 is being filed in two parts: this current report and another Form 4 of the reporting party filed on the same date. To minimize confusion, only the current report includes the information in Table II. As such, both this Form and the other Form 4 of the reporting party filed on the same date should be read in tandem. As a result of technological limitations of the EDGAR system, this Form 4 is being filed in two parts: this current report and another Form 4 of the reporting party filed on the same date. To minimize confusion, only the other report of the reporting party filed on the same date includes the information in Table II. As such, both this Form and the other Form 4 of the reporting party filed on the same date should be read in tandem. Prices ranged from $22.00 to $22.03 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a securityholder of the issuer. Sales made pursuant to a Rule 10b5-1 trading plan. /s/ Bryan T. Baldasare as Attorney-in-fact for John A. Kraeutler 2010-02-25 -----END PRIVACY-ENHANCED MESSAGE-----